Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA amplification in human gastric carcinomas

O Mor1, G N Ranzani, Y Ravia

  • 1Department of Human Genetics, Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel.

Cancer Genetics and Cytogenetics
|February 1, 1993
PubMed
Summary

Researchers found a specific amplified genomic domain in gastric cancer cell lines, also present in 3.6% of primary gastric tumors. This amplification was not found in other solid tumors, suggesting its relevance to gastric carcinoma progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generalization of Kirchhoff's law of thermal radiation: the inherent relations between quantum efficiency and emissivity.

Optics express·2025
Same author

A phase I study of panobinostat and ruxolitinib in patients with primary myelofibrosis (PMF) and post--polycythemia vera/essential thrombocythemia myelofibrosis (post--PV/ET MF).

Leukemia research·2019
Same author

Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial.

Breast cancer research and treatment·2018
Same author

Role of minimal residual disease in the management of acute myeloid leukemia-a case-based discussion.

Annals of hematology·2018
Same author

Diagnostic application of a capture based NGS test for the concurrent detection of variants in sequence and copy number as well as LOH.

Clinical genetics·2017
Same author

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Gastric carcinoma is a significant global health concern.
  • Genomic alterations, including gene amplification, play a crucial role in cancer development.
  • The BEK/K-sam gene, encoding growth factor receptors, is located in a frequently amplified region in gastric cancer cell lines.

Purpose of the Study:

  • To investigate the frequency and significance of genomic amplification at chromosome 10q26 in primary gastric carcinomas.
  • To determine if this amplification is specific to gastric cancer compared to other solid tumors.
  • To assess the association of gene amplification with tumor characteristics and stage.

Main Methods:

  • Analysis of genomic DNA from gastric carcinoma cell lines (KATO III, SNU-16) and primary gastric tumors.

Related Experiment Videos

  • Utilized techniques to detect gene amplification within a specific 200 kb genomic region at 10q26.
  • Examined amplification of additional genes (MYC, ERBB2, INT2) in primary gastric carcinomas.

    • Main Results:

    • A 200 kb genomic segment containing the BEK/K-sam gene was amplified in 3.6% of primary gastric carcinomas.
    • All amplified tumors were poorly differentiated.
    • No amplification of this region was observed in other tested solid tumors.
    • Including MYC, ERBB2, and INT2, the overall gene amplification frequency reached 19.4% in gastric carcinomas, associated with advanced stage.

    Conclusions:

    • The genomic region at 10q26, including the BEK/K-sam gene, is amplified in a subset of gastric carcinomas.
    • This amplification appears specific to gastric cancer and is linked to aggressive tumor features.
    • Gene amplification in solid tumors may be more common than previously recognized, highlighting potential therapeutic targets.